Back to search

Comparative Cost-Effectiveness of Conservative or Intensive Blood Pressure Treatment Guidelines in Adults Aged 35–74 Years

Data up to Jan 2025

Published2016
Citations36
References36

Total Citations Per Year

Abstract

References (36)

Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?

2016 • 11,500 citations

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

2002 • 9,810 citations

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

2012 • 8,841 citations

Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients

2000 • 8,612 citations

2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults

2013 • 7,509 citations

A Randomized Trial of Intensive versus Standard Blood-Pressure Control

2015 • 5,411 citations

Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus

2010 • 3,333 citations

Prevention of Stroke by Antihypertensive Drug Treatment in Older Persons With Isolated Systolic Hypertension

1991 • 2,850 citations

Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies

2009 • 2,611 citations

The J-Curve Phenomenon in Hypertension

2016 • 1,513 citations

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

1991 • 1,361 citations

Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials

2003 • 1,164 citations

Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories

2008 • 807 citations

Effects of Intensive Blood Pressure Lowering on Cardiovascular and Renal Outcomes: A Systematic Review and Meta-Analysis

2012 • 760 citations

Blood Pressure Lowering in Type 2 Diabetes

2015 • 750 citations

Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial

2013 • 674 citations

Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease

2016 • 570 citations

Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data

2014 • 569 citations

Comparative Effects of Ramipril on Ambulatory and Office Blood Pressures

2001 • 488 citations

ACC/AHA Statement on Cost/Value Methodology in Clinical Practice Guidelines and Performance Measures

2014 • 482 citations

ACC/AHA Statement on Cost/Value Methodology in Clinical Practice Guidelines and Performance Measures

2014 • 389 citations

Forecasting coronary heart disease incidence, mortality, and cost: the Coronary Heart Disease Policy Model.

1987 • 367 citations

Rethinking the Association of High Blood Pressure With Mortality in Elderly Adults

2012 • 323 citations

Evidence Supporting a Systolic Blood Pressure Goal of Less Than 150 mm Hg in Patients Aged 60 Years or Older: The Minority View

2014 • 314 citations

Cost-Effectiveness of Hypertension Therapy According to 2014 Guidelines

2015 • 231 citations

Cost-Effectiveness of Statin Therapy for Primary Prevention in a Low-Cost Statin Era

2011 • 168 citations

The Value Of Antihypertensive Drugs: A Perspective On Medical Innovation

2007 • 131 citations

Statin treatment for primary prevention of vascular disease: whom to treat? Cost-effectiveness analysis

2011 • 111 citations

Cost-Effectiveness and Population Impact of Statins for Primary Prevention in Adults Aged 75 Years or Older in the United States

2015 • 109 citations

Proportion of US Adults Potentially Affected by the 2014 Hypertension Guideline

2014 • 103 citations

Shared decision making in hypertension: the impact of patient preferences on treatment choice

2001 • 82 citations

The consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: a combined analysis of individual data of ADVANCE, EUROPA, and PROGRESS trials

2009 • 58 citations

Cost-effectiveness of Chlorthalidone, Amlodipine, and Lisinopril as First-step Treatment for Patients with Hypertension: An Analysis of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

2008 • 39 citations

Collaborative overview (‘Meta-Analysis’) of Prospective Observational Studies of the Associations of Usual Blood Pressure and Usual Cholesterol Levels with Common Causes of Death: Protocol for the Second Cycle of the Prospective Studies Collaboration

1999 • 22 citations

Effect of Intensive Versus Standard Blood Pressure Control on Depression and Health-Related Quality of Life in Type 2 Diabetes

2012 • 21 citations

The Diastolic J Curve

2011 • 21 citations

Cited By (0)

Loading...